Summary.-A tumour initiating dose of ethyl carbamate was administered to mice by subcutaneous injection together with a dose of one of the homologous esters or an ethyl N-alkyl derivative. The homologues used were the methyl, n-propyl and n-butyl esters, and the derivatives were the N-methyl, N-ethyl and N-n-propyl ethyl esters. The mice were then given promoting treatment with croton oil for 28 weeks.
THE administration of ethyl carbamate (urethane) to mice by any route leads to the production of tumours in a variety of tissues (Tannenbaum, 1964) . Adenomata of the lung (Nettleship et al., 1943; Shimkin, 1955) are very common. Lymphomata with or without leukaemia (Pietra et al., 1961) , haemangiomata of the liver (Trainin, 1963) , and hepatomata are less commonly found; tumours of lacrimal gland, skin and of other sites are observed infrequently and only after a long latent period. For skin its carcinogenic action is mainly that of an initiator, that is, tumours usually appear only when the skin is subsequently painted repeatedly with a promoting agent such as croton oil (Graffi et al., 1953; Salaman and Roe, 1953; Berenblum and Haran, 1955) .
The tumour initiating property of carbamates for skin appears to be limited to the ethyl ester and a few of its Nsubstituted derivatives (Berenblum et al., 1959b; Pound, 1967 Pound, , 1969 . The tumour producing property for lung also appears to be restricted to ethyl, ethyl N-methyl and N-hydroxy carbamates although propyl carbamate was considered to have a doubtful effect (Larsen, 1947 (Larsen, , 1948 Berenblum et al., 1959b) .
However, because of the common chemical structure it might be thought that the homologues, or the N-substituted derivatives, of ethyl carbamate might affect or be affected by similar metabolic systems within the cells of animals injected with them. Some related compounds appear to produce similar abnormalities of the chromosomes during mitosis in the cells of animals, some eggs and plants (Cornman, 1954; Boyland et al., 1965) , and lead to a similar depression of the white cell counts in mice (Skipper et al., 1949) . The injection of homologues or derivatives of ethyl carbamate at the same time as the ethyl ester might therefore modify the tumour producing properties of the latter. Garcia (1963) reported that injection of butyl carbamate at the same time as the ethyl ester reduced the number of tumours initiated in the skin. The experiments reported in this paper were carried out to examine this proposition.
MATERIALS AND METHODS

Mice
Random bred male mice of the strain " Hall " (Pound, 1962) , about 7 weeks of age and weighing 26 + 1 g at the beginning of the experiments, were used. The animals were divided into groups by random selection and were housed in stainless steel compartments each containing 10 mice with a bed of coarse sawdust that was changed weekly. The animals were fed the standard diet used previously and supplied with water ad libitum. The mouse room was kept at a temperature of 22°C. The hair on the skin of the back was clipped with electric clippers an hour or two before application of the tumour promoting agents to the skin.
Chemicals
The chemicals used were as follows: ethyl carbamate (British Drug Houses analytical reagent); methyl, isopropyl, n-butyl, ethyl N-methyl, ethyl N-ethyl Thus the mice were injected with 0-432 LD50 urethane in the controls. This was increased to 0-540, 0-650 and 0-864 LD50 by the additional amount of urethane in Experiments I, II and III respectively. The original plan was to inject the other carbamates in molecular equivalent amounts to the additional doses of urethane, but these doses were too lethal. The additional dose in each experiment was therefore selected at an arbitrary figure, standard for each experiment as set out in the tables below.
In Experiment I the doses of the homologues were as shown in Table II . From the 7th day after injection of the carbamates, the mice were painted over the whole area of the skin of the back with 0-25 ml of a 0.5%o solution of croton oil (A) in acetone once each week for 20 weeks. The time of appearance of the first tumour was noted and the numbers of tumours present recorded on charts at the 14th and 22nd weeks. The mice were then discarded without autopsy.
In Experiments II and III the additional doses of urethane were 12-5 mg and 25 mg respectively. The doses of homologues were increased in Experiment II and again in Experiment III as shown in Table III . From the 7th day after injection of the carbamates the mice were given an application of 0-25 ml of a 0.075% solution of croton oil (B) in acetone over the whole area of the skin of the back once weekly for 28 weeks. The time of appearance of the first tumour was noted and the number of tumours present on the painted area were recorded on charts at 12, 16, 20, 28, and 36 weeks. Animals that died before this time were discarded without autopsy. After the 40th week obviously sick animals were killed and with the remaining animals, which were all killed at 50 weeks, subjected to autopsy. A few animals died undetected early enough to be suitable for autopsy. Skin lesions that were considered to be malignant or doubtfully malignant were confirmed by histological examination, but it was not practical to section all lesions. The number of mice with lung adenomata and the number of lesions were counted. Haemangiomata and hepatomata in the liver were counted and the diagnosis confirmed histologically. The number of mice with leukaemia was noted; enlargement of the spleen and/or the thymus was accepted as evidence of leukaemia, but in occasional cases blood smears or histological sections were examined.
RESULTS
General Toxic and Narcotic Effects
The depth of narcosis produced by the basal dose of ethyl carbamate was increased, as expected, by the additional (Pound, 1967) . The sums of the fractions of the LD50 are also shown. The number of survivors expected for the total fraction of the LD50 does not differ significantly from the number of survivors actually found. The narcotic and toxic properties of the several carbamates are therefore additive when the doses are considered as fractions of the LD50. Apart from the early deaths due to narcosis, the death rates in the 3 experiments and in all groups of each experiment do not differ significantly.
Classification of Skin Tumours
The skin tumours that arise after initiation by urethane, followed by promoting treatment with croton oil, behave in a variety of ways that enable them to be classified for the purpose of this paper as benign papillomata, doubtfully malignant lesions or carcinomata.
Benign papillomata
These constitute the majority of growths. The lesions are first identified when about 1 mm in diameter. A number of lesions grow for a time and regress during the treatment with croton oil, but some continue to grow and may reach a size ranging from 3 to 10 mm diameter. Growth may continue even after cessation of the croton oil treatment, and further lesions may reach detectable size. As the lesions age after cessation of the promoting treatment a further proportion undergo regression.
Histologically these lesions are typical papillomata clothed by hyperplastic stratified squamous epithelium of regular character with a varying amount of keratin formation, sometimes abundant. As the lesions age they become less vascular and form more keratin. Some finally atrophy and disappear, but occasional lesions become necrotic and are sloughed off.
Doubtfully malignant lesions
A proportion of the lesions commence to grow in a similar manner to benign papillomata but grow progressively and may reach a considerable size, e.g. 12-15 mm in diameter. These lesions remain vascular, become fleshy, and may differ considerably in appearance from the benign lesions. They may have a broad pedicle or sit well into the dermis.
Histologically these lesions have a papillary structure clothed by a deeply staining active squamous epithelium with many mitoses, and usually form much keratin. The epithelium shows varying degrees of invasion at the base, into the dermis, or even into the underlying fat.
Lesions of this type rarely regress in the period of observation. In this experiment an occasional pedunculated lesion sloughed off probably following mechanical trauma during clipping. In one instance in which this occurred, a squamous cell carcinoma developed later at the site. The impression has been formed that a substantial proportion of these lesions would become carcinoma if their growth had been allowed to continue.
Carcinomata
A further proportion of the lesions become frank carcinoma during the period of observation. Histologically these vary from moderately well differentiated squamous cell carcinomata to anaplastic spindle-celled growths, with invasion of the deeper tissue, the muscularis panniculous carnosus, and even the body musculature.
Tumour Yields
The number of mice with tumours of the skin and the number of skin tumours in each group at the 14th and 22nd week Table III. Table IV sets out the data from autopsy of animals that died after the 40th week or were killed at 50 weeks. Skin tumours were classified as above from the clinical behaviour in vivo, or from sections of doubtful lesions taken at autopsy.
Comparison of the tumour yields in the skin of the control groups injected with 25 mg of urethane in Experiments I, II, and III after approximately 20 weeks' promoting treatment shows that the number of mice with tumours, and the total number of tumours in the surviving mice, are approximately the same in Experiments II and III but that the yield of tumours is significantly greater in these experiments than in Experiment I (for the number of tumours per surviving mice x2= 9-22, 2 d.f., P < 0.01). This is probably due to a greater promoting efficiency of the croton oil (B) used in Experiments II and III which was effective as a 0.075% solution in acetone as compared with the 0-5% solution of croton oil (A) used in Experiment I. In both instances the concentrations were about the maximum that could be used without producing ulceration of the skin.
The results of Experiment I (Table II) The results of Experiments II and III (Tables III and IV) may be considered together since the results show no significant variation in the tumour yields in the control groups injected with 25 mg of urethane. Apart from the early deaths due to toxic effects of the carbamates, the death rates do not differ in the 2 experiments.
If the Groups 9 in Experiments II and III are excluded, there is no significant variation in the number of mice with skin tumours or in the number of tumours in the surviving mice at 12, 20, 36, and 50 weeks after the administration of the urethane. There is no significant variation in these groups in the proportion of surviving mice with adenomata in the lungs, nor in the number of adenomata. The number of tumours in the liver, haemangiomata and hepatomata, and the number of mice with leukaemia do not vary significantly between the groups.
On the other hand, the number of tumours in the surviving mice is significantly greater in Group 9 of each ..a experiment, which received the additional dose of urethane (Experiment II, x2 9-4 1 d.f., P < 0 005 at 36th week; Experiment III, x2 49 1 d.f., P < 0-001 at 36th week). Further, the tumour yield is greater in the mice in Group 9 of Experiment III, which had a dose of 50 mg of urethane, than in Group 9 of Experiment II which had 37'5 mg. The increased tumour yields in Group 9 of Experiments II and III are significant at the 12th, 20th, 36th, and 50th weeks. The proportion of the surviving mice with lung tumours and the number of lung adenomata are also increased in Groups 9 of Experiments II and III. The number of lung adenomata is significantly greater in Group 9 of Experiment III than in Group 9 of Experiment II, in conformity with the larger dose of urethane.
The number of liver tumours and the number of mice with leukaemia do not vary significantly in any group but the numbers are too small to allow any valid conclusion.
It is evident that the number of tumours increases steadily from the time of appearance of the first tumours at about the 8th week for about 36 weeks and thereafter declines. Since the applications of croton oil were discontinued after 28 weeks, tumours must continue to develop for a time after cessation of the promoting treatment before the number regressing becomes greater than the number of new ones appearing. In these experiments many tumours eventually regressed. On the other hand, the number of malignant tumours increased steadily from the time they were first recognized.
DISCUSSION
It is relevant to the present issue that, when a given dose of urethane was injected together with graded doses of one or other of its homologues or N-substituted derivatives, the narcotic potencies of the combined injections were such as to be expected if the toxicity of the compounds is additive in accordance with Ferguson's rule (Ferguson, 1939) .
16 § When the mice were given a fixed tumour initiating dose of ethyl carbamate, the simultaneous injection of one of the homologous methyl, propyl, and ethyl carbamates, or of the related ethyl N-methyl, N-ethyl, or N-propyl carbamates, did not produce any significant change in the tumour yield in any tissue. The proportion of mice that developed skin tumours and the total number of skin tumours in the surviving mice was unaltered at any stage after promoting treatment was commenced, that is, the rate of production of tumours and the rate of regression was unaltered and, moreover, the number of malignant tumours was also unchanged.
On the other hand, an increase in the dose of ethyl carbamate increased the number of lung tumours, the number of tumours in the liver, and perhaps the incidence of leukaemia. It produced an increase in the yield of skin tumours at all times after promoting treatment was commenced, and in the proportion of skin tumours that were malignant. A similar increased yield of tumours with increasing dose of urethane has been found by others (Berenblum and Haran-Ghera, 1957; Roe and Salaman, 1954) .
The failure of the homologous alkyl carbamates to increase the tumour yield is consistent with previous work, suggesting that these compounds have very little, if any, potency as tumour producing agents in mice for skin and lung (Larsen, 1947 (Larsen, , 1948 Berenblum et al., 1959b; Pound, 1967 and unpublished data). The fact that they, as well as the N-substituted derivatives of ethyl carbamate, had no effect on the tumour yield substantiates the view that the biochemical events resulting in the production of tumours by urethane are not related to those cellular processes that result in narcosis. This view was formerly based on observations that the tumour producing properties and the narcotic properties of carbamates depend on different chemical features of the molecule (Berenblum et al., 1959b; Pound, 1967 Pound, , 1969 , and that the adminis-tration of lysergic acid diethylamide (LSD-25) at the same time as urethane obviates the narcosis but does not influence the tumour yields (Berenblum et al., 1959a) .
Ethyl-N-methyl carbamate, however, is more than half as potent as ethyl carbamate, while ethyl-N-ethyl and ethyl-N-propyl carbamates are progressively less active in their tumour initiating property for mouse skin and tumour producing property in mouse lung (Berenblum et al., 1959b; Pound, 1967 and unpublished data). The higher doses of ethyl-N-methyl carbamate would probably be effective if given alone and perhaps should be expected to lead to increased tumour yields when given together with ethyl carbamate if the tumour producing effects were simply additive in the same way as an addition to the dose of urethane, particularly since they are chemically closely related and probably act through the same metabolic pathways. Nevertheless, no significant increase in tumour yields was found. Perhaps further information on this point might be obtained. However, the carcinogenic potency of carbamates appears to be fairly specific to the ethyl esters with not more than one hydrogen substituted on the amide nitrogen (Pound, 1967 (Pound, , 1969 , suggesting the existence of a specific metabolic pathway to an active intermediate. The present result suggests that the unsubstituted ethyl carbamate is metabolized to the active carcinogen in preference to the Nsubstituted compounds when both are present in an animal. Garcia (1963) reported that the administration of butyl carbamate at the same time as the ethyl ester reduced the number of skin tumours obtained after subsequent promoting treatment with croton oil. The discrepancy with the present results may be related to the fact that he administered the compounds as a series of small injections, over a period which appears to have been about 23 days in one group, although the actual dosage schedules were not set out. These conditions are likely to induce the formation of enzymes that metabolize the compounds, as is known to occur in the case of ethyl carbamate (Conney, 1965) and the dicarbamate meprobamate (Phillips et al., 1962) , so that less is available for carcinogenic action. A report that the administration of ethyl carbamate as a course of injections over several days resulted in the initiation of fewer tumours than if it had been given as a single large dose (Berenblum and Haran-Ghera, 1957) possibly reflects a similar phenomenon. This work was supported by grants from the Queensland Cancer Fund and the Mayne Bequest Fund of the University of Queensland.
